Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT07107802
Phase 1 Single Ascending Dose Study With ATX101
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 19, 2025
Completion: Nov 14, 2025